update
Catalent signs cell line deal with Japanese CMO
Catalent Pharma Solutions will supply Japanese CMO Unigen with cell lines under an agreement announced today.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
update
Catalent Pharma Solutions will supply Japanese CMO Unigen with cell lines under an agreement announced today.